Jeffrey H. King

Statistics

Publications

Citations

471

H-Index

Active since

1983

Affiliations

University of California Davis Medical Center(Current)

University of California, San Francisco

Jeffrey H. King is an author at University of California Davis Medical Center specializing in anticoagulant therapy, anticoagulation therapy, and medicine.

Publications per year

1983–2004

Publications

Optimization of Inpatient Warfarin Therapy: Impact of Daily Consultation by a Pharmacist-Managed Anticoagulation Service

William E. Dager, Jennifer M Branch, Jeffrey H. King et al. · Annals of Pharmacotherapy · 2000 · 125 citations

Pharmacy, Hospital Pharmacy, Pharmacy Practice +17

Effect of Direct Thrombin Inhibitors, Bivalirudin, Lepirudin, and Argatroban, on Prothrombin Time and INR Values

Robert C. Gosselin, William E. Dager, Jeffrey H. King et al. · American Journal of Clinical Pathology · 2004 · 93 citations

Medicine, Pharmacology, Pharmacotherapy +17

Effect of Direct Thrombin Inhibitors, Bivalirudin, Lepirudin, and Argatroban, on Prothrombin Time and INR Values

Robert C. Gosselin, William E. Dager, Jeffrey H. King et al. · American Journal of Clinical Pathology · 2004 · 91 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17

Comparing Direct Thrombin Inhibitors Using aPTT, Ecarin Clotting Times, and Thrombin Inhibitor Management Testing

Robert C. Gosselin, Jeffrey H. King, Kim Janatpour et al. · Annals of Pharmacotherapy · 2004 · 60 citations

Medicine, Hematology, Pharmacology +17

Effects of pentasaccharide (fondaparinux) and direct thrombin inhibitors on coagulation testing.

Robert C. Gosselin, Jeffrey H. King, Kim A. Janatpur et al. · PubMed · 2004 · 34 citations

Medicine, Hematology, Pharmacology +17

1–5 of 8